pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Small Molecules · news · pharmadog
← back to Small Molecules
News mentioning Small Molecules
18
stories
21h
STAT+: One of the most consequential years for cancer treatment, ever
stat
1d
Kolon TissueGene cuts 37 US staffers after Phase 3 fail
biospace
2d
BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
fiercebiotech
6d
Capricor soars on potential FDA review extension, filing amendments
biospace
6d
‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery
fiercebiotech
7d
Chutes & Ladders—Former Legend CEO lands at K2
fiercebiotech
8d
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
fiercebiotech
9d
With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
biospace
9d
Building Resilience for the Future of Biopharma Innovation
fiercebiotech
10d
BMS picks Texas for new $2.3B manufacturing campus
biospace
10d
Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
biopharma dive
10d
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
fiercebiotech
11d
Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program
fiercebiotech
14d
LifeMine raises $263M in mission to improve organ transplant aftercare
biospace
Jul 17, 26
BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fields
fiercebiotech
Jul 13, 26
Biotech startup funding gap widens despite rebound in VC investment
biopharma dive
Jul 6, 26
Cancer, immune drugmakers dominate VC funding so far in 2026
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
